E. Dompeling

FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes.

J. Roukema, M. C. Hagemeijer, A. Vonk, 2023, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.